D, A., R, R., G, M., A, B., T, S., P, T., & MR, R. (2021). Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab. Dove Medical Press.
Cita Chicago Style (17a ed.)D, Allegrini, Raimondi R, Montesano G, Borgia A, Sorrentino T, Tsoutsanis P, y Romano MR. Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab. Dove Medical Press, 2021.
Cita MLA (8a ed.)D, Allegrini, et al. Short-Term Outcomes After COVID-19-Related Treatment Interruption Among Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Bevacizumab. Dove Medical Press, 2021.